Una guía técnica para gerentes de control de calidad/validación, gerentes de producción y equipos de adquisiciones que evalúan cómo los trapeadores estériles para salas blancas mantienen la esterilidad a través del empaque, los procedimientos de transferencia y la alineación regulatoria, desde el sello del fabricante hasta el punto de uso de Grado A/B.
Transferencia aséptica de una fregona estéril para sala blanca es el procedimiento mediante el cual se introduce una fregona esterilizada terminalmente en un área aséptica clasificada (generalmente Grado A/B según el Anexo 1 de GMP de la UE) sin comprometer el estado estéril de la fregona ni la clasificación ambiental de la zona receptora.
La esterilidad no es un atributo de un solo punto conferido por la esterilización terminal. es un cadena de esterilidad que debe mantenerse en cada eslabón: esterilización validada por el fabricante, sello de embalaje intacto, transporte controlado, recepción adecuada en las instalaciones, transferencia gradual zona por zona a través de esclusas de aire del material y desenvoltorio final solo en el punto de uso inmediato.
Un enfoque sólido de transferencia aséptica se basa en tres pilares:
Embalaje validado, generalmente de doble bolsa, que proporciona barreras selladas de forma independiente que respaldan la descontaminación por etapas y el desenvoltorio respetuoso con la zona.
Un procedimiento documentado y reproducible que hace coincidir la eliminación de cada capa de embalaje con el límite de grado de sala blanca adecuado.
Controles visuales y documentados en la recepción y en cada etapa de transferencia para confirmar que la barrera estéril no se ha visto comprometida.
En cuanto al embalaje en bolsa única versus en bolsa doble: la bolsa única proporciona una barrera estéril, que puede evaluarse en instalaciones donde toda la ruta de transferencia se encuentra dentro de un espacio clasificado. La doble bolsa proporciona dos barreras selladas de forma independiente: la bolsa exterior se retira en Grado C/D después de la descontaminación de la superficie, mientras que la bolsa interior permanece sellada hasta que se necesita el trapeador en el punto de uso de Grado A/B. Para la mayoría de las instalaciones de procesamiento aséptico que operan según el Anexo 1, el doble embolsado es el enfoque estándar porque proporciona una transferencia verificable y por etapas con una barrera de contaminación alternativa.
La esterilización terminal confirma que un trapeador de sala blanca estaba estéril en el momento en que se completó el ciclo de esterilización. No confirma que el trapeador sea estéril cuando un operador lo retira del empaque dentro de una zona de Grado A días o semanas después. El concepto de cadena de esterilidad cierra esta brecha: trata la esterilidad como un condición sostenida que debe mantenerse en cada paso entre la liberación del fabricante y el desenvoltorio en el punto de uso.
Un trapeador esterilizado se define como estéril en el fabricante, pero el comprador necesita que el trapeador esté esterilizado en el punto de uso. La brecha entre estos dos estados es el dominio de la transferencia aséptica, y es donde se originan muchos fallos de esterilidad.
Comprender los modos de falla es esencial para diseñar procedimientos de transferencia sólidos. Los puntos de ruptura comunes de la cadena de esterilidad incluyen:
El Anexo 1 de las GMP de la UE (Sección 8: Producción y tecnologías específicas, que cubre la tecnología de barrera y los sistemas de transferencia) establece expectativas sobre cómo se introducen los consumibles estériles en las áreas de procesamiento aséptico. Por separado, FDA 21 CFR Parte 211, particularmente la Subparte F (Controles de producción y proceso), establece requisitos para que los materiales utilizados en el procesamiento aséptico se manipulen de una manera que no comprometa la esterilidad. Si bien ninguna de las regulaciones prescribe explícitamente una configuración de empaque específica, ambas establecen el principio de que la transferencia de material estéril debe ser controlada, documentada y reproducible.
En la práctica, esto significa que el procedimiento de transferencia de consumibles estériles de una instalación, incluida la forma en que los trapeadores de sala limpia ingresan a las zonas de Grado A/B, cae dentro del alcance de la revisión de la estrategia de control de la contaminación por parte de un auditor. Un trapeador que llega etiquetado como "estéril" pero que carece de un procedimiento de transferencia validado y documentado puede convertirse en una observación de auditoría independientemente del estado de esterilidad inicial del producto.
La configuración del empaque no es una elección cosmética ni una venta adicional. Es una decisión de control de la contaminación que determina directamente qué protocolos de transferencia son posibles y cómo se mantiene la cadena de esterilidad a través de las transiciones de zona. Las dos configuraciones principales (bolsa única y bolsa doble) admiten lógicas de transferencia fundamentalmente diferentes.
El embalaje en una sola bolsa proporciona una barrera sellada entre el trapeador estéril y el ambiente externo. El trapeador se esteriliza terminalmente, se sella, se etiqueta con información de lote y esterilidad y se envía como una barrera estéril de una sola unidad.
El embolsado único se puede evaluar en instalaciones donde toda la ruta de transferencia, desde la recepción hasta el almacenamiento y el punto de uso, se encuentra dentro de una sala limpia clasificada (por ejemplo, almacenamiento interno de Grado C con paso directo de esclusa de aire del material al Grado B). En dichas instalaciones, el exterior del embalaje no está expuesto a entornos no controlados, lo que reduce potencialmente la necesidad de una etapa de descontaminación exterior.
El embalaje de doble bolsa proporciona dos barreras selladas de forma independiente que respaldan la descontaminación por etapas y el desempaquetado zona por zona. Cada capa de bolsa corresponde a un límite de grado de sala blanca en la ruta de transferencia.
Cada capa de bolsa coincide con un límite de zona en la ruta de transferencia. La bolsa exterior se descontamina y se retira en el límite de Grado C/D. La bolsa interior, que no ha estado expuesta a superficies externas en ningún punto, se transporta a través de la ruta de transferencia de Grado B hasta el Grado A. Este enfoque por etapas significa que incluso si la bolsa exterior se ve comprometida o contaminada durante el almacenamiento, la bolsa interior proporciona una barrera estéril verificada hasta el punto de uso.
| Comparison Dimension | Bolsa única | Doble bolsa |
|---|---|---|
| Number of sealed barriers | 1 | 2 (independently sealed) |
| Transfer logic | Direct unwrap at point of use (requires cleaner transfer path) | Staged unbagging: outer at Grade C/D, inner at Grade A/B |
| Alineación del Anexo 1 | Puede requerir justificación procesal adicional | Admite la transferencia respetuosa con la zona por diseño |
| Complejidad del operador | Bajar (un paso para desenvolver) | Superior (requiere procedimiento por etapas y capacitación) |
| Riesgo si el embalaje se ve comprometido | Esterilidad perdida: no hay barrera alternativa | El exterior está comprometido: el interior proporciona un respaldo |
| Contexto típico de una instalación | Ruta de transferencia completa dentro de una sala limpia clasificada | Instalación multizona con esclusa de material/infraestructura de paso |
| Carga de documentación | Certificación de esterilidad estándar, especificación de embalaje. | Certificación de esterilidad estándar, especificación de embalaje; Se recomienda documentación adicional de SOP de transferencia |
Esta tabla describe las configuraciones de embalaje de la industria general como dimensiones de evaluación para los compradores. No representa datos de rendimiento específicos de MIDPOSI ni una afirmación de superioridad del empaque. Las instalaciones deben verificar configuraciones de embalaje específicas directamente con los proveedores durante la evaluación.
MIDPOSI ofrece trapeadores estériles para salas blancas en configuraciones que incluyen opciones de empaque de doble bolsa diseñadas para transferencia aséptica por etapas. El embalaje incorpora barreras selladas de múltiples capas con etiquetado de trazabilidad a nivel de lote, y los envíos estériles van acompañados de un Certificado de Esterilidad específico del lote. Para especificaciones de embalaje específicas y configuraciones de trapeadores estériles, consulte la Embalaje de fregona estéril para sala blanca con doble bolsa detail page. Sterile configurations are available in 40g, 55g, and 65g options within the White Cleanroom Mop Series.
Importante: The procedure below is a general framework based on industry transfer principles and Annex 1 guidance. It is intended as a reference for facilities developing or reviewing their own transfer SOPs. Each facility must validate its specific procedure based on its cleanroom layout, material airlock configuration, cleanroom grade boundaries, and internal risk assessment. This framework should be adapted — not adopted verbatim — into facility-specific SOPs.
Before initiating the physical transfer, complete and document the following checks:
Inspect both outer bag and (where visible through outer bag) inner bag for seal breaches, holes, abrasion, or moisture condensation inside the packaging. Any compromised unit should be quarantined and documented.
Cross-check the batch/lot number on the packaging label against the batch-specific Certificate of Sterility. Mismatch is a red flag — do not proceed until resolved.
Check the expiration or sterility shelf-life date. Expired sterile product should not be introduced into classified aseptic zones regardless of visual packaging appearance.
Si la superficie exterior de la bolsa está visiblemente sucia, mojada o muestra signos de exposición química, ponga la unidad en cuarentena. Una superficie exterior visiblemente contaminada puede indicar un compromiso más profundo del embalaje.
Utilice un desinfectante validado para el protocolo de sala limpia de la instalación. El desinfectante debe ser compatible con el material de embalaje (verifique con el proveedor si no está seguro). Documente el lote de desinfectante y el tiempo de contacto.
Verify that the airlock or pass-through is not in an alarm state, maintenance mode, or occupied by another transfer. The airlock cycle should complete normally before entry.
Transfer personnel must be gowned to the standard of the zone they are operating in. Gloves should be inspected for integrity before handling packaging.
The surface where the outer bag will be opened (Grade C) must be clean and free of items that could compromise the inner bag during outer bag removal.
Planifique dónde se eliminarán la bolsa exterior retirada (flujo de desechos de Grado C/D) y la bolsa interior (flujo de desechos de Grado A). Los embalajes no deben acumularse en los puntos de transferencia.
Registre todos los datos de verificación previos a la transferencia en el registro de transferencias. Esta documentación respalda la trazabilidad de lotes y la defensa ante auditorías.
Place the double-bagged sterile mop in the material airlock or pass-through. Apply surface decontamination to the outer bag using a validated disinfectant with the facility’s documented contact time. Do not rush the contact time — it is a validated parameter. Once the decontamination cycle is complete, close the airlock and allow the transfer cycle to run. The mop remains in the airlock until the cycle indicates completion and the Grade C-side door is ready to open.
This step ensures that the outer bag surface, which may have been exposed to storage or transport environments, is decontaminated before it enters the classified cleanroom envelope.
After the airlock cycle completes, enter from the Grade C side and retrieve the decontaminated package. Place it on a clean, prepared surface within the Grade C receiving area. Remove the outer bag by opening the seal without tearing — tearing can generate particles and may damage the inner bag. Discard the outer bag into Grade C waste.
Immediately inspect the inner bag for integrity: confirm no visible punctures, moisture, abrasion, or seal damage. The inner bag surface should be clean and dry. Any compromise at this stage means the unit should not proceed further — quarantine and document. If the inner bag is intact, it is now ready for transfer to the next zone.
Carry the sealed inner bag to the Grade C-to-B material airlock. If the facility protocol requires surface decontamination of the inner bag before Grade B entry, apply the validated disinfectant with the documented contact time. Note: the inner bag has been protected by the outer bag throughout preceding stages, so surface contamination risk is reduced. However, some facilities elect to decontaminate as an additional precaution — follow your facility’s validated SOP.
Allow the airlock cycle to complete. Enter from the Grade B side. The operator at this stage should be gowned to Grade B standard. Minimize contact with the inner bag surface — handle by edges or designated handling areas. The inner bag remains sealed throughout this stage.
Carry the sealed inner bag to the immediate point of use within the Grade A workstation or aseptic filling zone. Do not open the inner bag until you are at the exact location where the mop will be used. Opening the inner bag earlier — even within Grade B — exposes the sterile mop to contamination risk that may not be mitigated by the Grade B environment alone.
At the point of use: open the inner bag seal, retrieve the sterile mop, and immediately attach it to the cleanroom mop frame. The frame itself must be pre-cleaned or sterilized to the zone’s standard — a sterile mop attached to a non-sterile frame creates an immediate contamination control gap. Remove the used inner bag packaging from the Grade A zone immediately after mop retrieval. Do not set the packaging down in the aseptic zone.
Packaging integrity is the physical condition of the sterile barrier. Verifying it is a structured, documented activity — not a glance at the box. For facilities operating under GMP, the verification process should be integrated into the incoming QA workflow with defined acceptance criteria, documentation requirements, and quarantine procedures for non-conforming units.
The first integrity check occurs when the shipment arrives at the facility. Before the mop enters the cleanroom transfer path, inspect for:
Check all packaging seals for gaps, tears, incomplete seals, or seal separation along package edges. A continuous, uniform seal without channeling or delamination is the expected baseline. Heat-sealed packaging should show consistent seal width across the full perimeter.
Inspect the full surface area of the outer packaging for punctures, abrasions, compression damage (crushed edges, folded corners that may have compromised seal), or cuts. Pay particular attention to corners and edges — these are common failure points during transport.
Visible moisture, condensation, or liquid staining inside the packaging indicates a seal failure or improper storage condition. Even if the external seal appears intact, internal moisture is a contamination risk and should trigger quarantine.
If the packaging includes a sterilization indicator (e.g., a color-change indicator strip), note that its purpose and limitation are often misunderstood:
This distinction is important for auditor discussions. Do not present a sterilization indicator as evidence of continued sterility. Packaging integrity — not the indicator — is the relevant check for ongoing sterility assurance.
In parallel with physical inspection, cross-check the shipment documentation:
Packaging integrity verification should not be an ad-hoc activity. It should be a documented step in the material release process:
Record: date, receiving personnel, supplier batch number, visual inspection result (pass/fail/observation), documentation cross-check result, and disposition (accept/quarantine/reject).
Any unit with: visible seal breach, puncture, moisture inside packaging, batch/documentation mismatch, or expired sterility shelf life should be quarantined pending investigation. Do not transfer compromised units into the cleanroom.
The packaging integrity check result should be a gating step in the material release process. No sterile mop should be released for cleanroom transfer without a documented, passing integrity check.
Note on Annex 1 scope: EU GMP Annex 1 is a regulatory guideline for the manufacture of sterile medicinal products. Compliance is assessed at the facility level — not at the individual product level. A sterile mop or its packaging cannot be “Annex 1 certified” or “Annex 1 compliant” as a standalone product. Rather, a sterile mop supplier’s packaging design, documentation package, and transfer guidance can support o facilitate a facility’s Annex 1 alignment. The discussion below focuses on what features buyers should evaluate in a supplier’s packaging and documentation to assess whether those features are consistent with Annex 1 expectations for sterile material transfer.
Several Annex 1 principles directly inform how sterile cleanroom mop packaging and transfer should be evaluated:
These principles do not explicitly prescribe double-bagging, a specific packaging material, or a specific transfer sequence. Rather, they establish the outcome that must be achieved: sterile items arrive sterile at the point of use, and the facility can demonstrate how. Packaging and transfer procedure are the two mechanisms that achieve this outcome.
Double-bagging is not explicitly mandated by Annex 1. However, it is the industry-standard packaging approach for sterile consumables used in aseptic processing because it structurally supports the Annex 1 transfer principles:
For facilities evaluating Annex 1 alignment, see the broader regulatory context in the Trapeador farmacéutico para salas blancas Cumplimiento con GMP Anexo 1 article.
During a GMP audit of an aseptic processing facility, auditors may review the following in relation to sterile consumable transfer — including cleanroom mops:
The table below provides a structured framework for evaluating a sterile mop supplier’s packaging and documentation against Annex 1-aligned facility expectations. This is a buyer-side evaluation tool — not a compliance claim about any specific supplier.
| Elemento de la lista de verificación | What to Ask the Supplier | What to Document Internally |
|---|---|---|
| Sterility certification | Is a batch-specific Certificate of Sterility provided with each shipment? | File COS with batch number and receiving date in incoming QA records |
| Packaging design | Is the packaging designed for staged aseptic transfer (multi-layer packaging configuration)? | Document packaging configuration in supplier qualification file |
| Trazabilidad de lotes | Is full batch traceability from sterilization lot to shipment available? | Link supplier batch number to internal receiving/inventory record |
| Transfer documentation | Does the supplier provide packaging integrity and transfer guidance? | Integrate supplier guidance into internal transfer SOP as reference input |
| Seal integrity | What packaging integrity checks does the supplier perform before shipment? | Define incoming visual inspection criteria and documentation requirements |
| Expiry / shelf life | What is the labeled sterility shelf life, and how is it validated? | Document shelf-life monitoring process and quarantine procedure for expired units |
This checklist is a buyer-side evaluation tool. Individual facilities should adapt it to their specific Annex 1 scope, internal risk assessment, and supplier qualification SOP. The items above represent commonly reviewed dimensions — facilities may add or remove items based on their regulatory framework and cleanroom classification.
“Can you provide the Certificate of Sterility with batch-level traceability?”
A generic sterility claim without batch-specific documentation does not support internal batch release or audit defense. Batch-level traceability is a minimum expectation for sterile consumables used in GMP-governed facilities.
“Is your sterile mop packaging designed for staged aseptic transfer?”
This question assesses whether the supplier’s packaging configuration (single-bag, double-bag, or other) aligns with the facility’s transfer infrastructure. The answer informs whether the facility can integrate the product into its existing transfer SOP or whether procedural adaptation is needed.
“What packaging integrity testing does your production include as standard?”
Understanding the supplier’s outgoing quality checks provides context for the facility’s incoming inspection. A supplier with documented packaging integrity testing as part of production release provides a stronger sterility chain starting point.
“Do you provide documentation to support our internal Annex 1 compliance audit?”
Evaluate whether the supplier’s standard documentation package (COS, COC, batch traceability, packaging guidance) is sufficient to support the facility’s audit documentation requirements, or whether additional documentation must be requested and negotiated.
Even well-intentioned facilities can create sterility chain gaps through protocol shortcuts, documentation omissions, or misplaced assumptions. The following six mistakes are observed across aseptic processing environments and represent high-value areas for SOP review.
Why it happens: operator efficiency pressure, lack of training on zone-respecting transfer logic, or a belief that “removing packaging early saves time in the cleanroom.” Why it is wrong: exposing the sterile mop to an uncontrolled environment breaks the sterility chain before the mop enters the classified zone. The mop is effectively non-sterile from that point forward, regardless of its initial sterility status. Correction: implement staged unbagging at each zone boundary, enforce through documented SOP and training reinforcement, and include staged unwrap verification in supervisor oversight routines.
Why it is wrong: the outer bag may carry environmental contaminants from storage, transport, and handling. Introducing a non-decontaminated surface into a pass-through risks cross-contamination of the airlock interior and the inner bag when the outer bag is subsequently handled in Grade C. Correction: implement a defined decontamination step with a validated disinfectant and documented contact time. Make decontamination a gated step — the pass-through entry does not begin until decontamination is completed and documented.
Why it is wrong: not all “sterile” packaging configurations support staged aseptic transfer. A single-bag product requires a different (and often more restrictive) transfer protocol than a double-bag product. Assuming all sterile packaging is functionally equivalent can lead to a mismatch between the purchased packaging configuration and the facility’s actual transfer procedure. Correction: verify packaging specification and aseptic transfer documentation during supplier qualification — not after the first delivery. Match the packaging configuration to the facility’s transfer SOP, and if there is a mismatch, either adapt the SOP (with validation) or select a different packaging configuration.
Why it is wrong: without receiving inspection records, there is no auditable evidence that packaging was visually intact when the shipment was accepted. If a sterility failure is later identified and traced to compromised packaging, the investigation has no documented starting point — making root cause analysis and corrective action more difficult. Correction: integrate visual packaging integrity check into the incoming QA workflow as a documented step. Record inspection results. Quarantine shipments with packaging observations. Make the integrity check result a prerequisite for material release.
Why it is wrong: aseptic transfer is operator-dependent. Without periodic refreshers and documented competency assessment, drift in practice occurs — steps are abbreviated, contact times are shortened, or bag removal sequences are modified for convenience. Correction: implement periodic retraining on aseptic transfer procedures. Document competency assessments. Link training frequency to deviation and observation trends — if transfer-related deviations increase, training should be reviewed and potentially refreshed regardless of the scheduled cycle.
Why it is wrong: a general sterility claim without batch-specific documentation cannot support internal batch release for GMP-governed facilities. During an audit, a facility that uses sterile consumables but cannot produce batch-specific sterility certificates has a documentation gap that can be cited as a compliance observation — even if the consumables themselves were, in fact, sterile. Correction: require a batch-specific Certificate of Sterility as part of supplier qualification. Verify that each shipment’s documentation includes the batch number, sterilization date, and sterility assurance information. File documentation with the shipment record.
Aseptic transfer is one dimension of sterile cleanroom mop management. The following topics expand the evaluation scope and are relevant for buyers who have established their transfer procedure and are now optimizing the broader sterility assurance program.
Aseptic transfer is the documented procedure for introducing a terminally sterilized cleanroom mop into a classified aseptic area (Grade A/B) through staged zone transitions — without compromising the mop’s sterile state or the environmental classification of the receiving zone. It typically involves multi-layer packaging, surface decontamination at zone boundaries, zone-respecting unbagging, and documentation at each stage. The procedure ensures that sterility is maintained from the manufacturer’s seal through to the point of use, not just at the moment of terminal sterilization.
Double-bagging provides two independently sealed barriers that support a staged transfer procedure aligned with cleanroom grade boundaries. The outer bag is decontaminated and removed in a lower-grade area (Grade C/D), protecting the inner bag from environmental contamination. The inner bag remains sealed and is carried into Grade A/B, opened only at the immediate point of use. This design provides a verifiable transfer with a fallback contamination barrier: if the outer bag is compromised during storage or transport, the inner bag maintains sterility. For aseptic processing under Annex 1, double-bagging is the industry-standard approach because it structurally supports zone-respecting sterile material introduction.
It may be evaluated depending on facility infrastructure and risk assessment. Single-bagging requires that the entire transfer path — from receiving through storage to point of use — is within a classified environment, and that the single packaging layer’s integrity can be assured throughout. For most pharmaceutical aseptic processing facilities governed by Annex 1, double-bagging is the standard practice because it provides a staged, verifiable transfer with a fallback contamination barrier. A facility using single-bagging would need to provide a documented justification and risk assessment demonstrating equivalent sterility assurance. The evaluation should be documented in the facility’s contamination control strategy.
A general framework includes: (1) Pre-transfer visual inspection and documentation verification; (2) Surface decontamination of the outer bag at the material airlock entry (Grade D/C boundary); (3) Transfer into Grade C via pass-through or material airlock; (4) Outer bag removal in Grade C — inspect inner bag integrity after removal; (5) Transfer the sealed inner bag through the Grade C-to-B material airlock (optionally decontaminate inner bag surface per facility protocol); (6) Carry the sealed inner bag to the Grade A point of use; (7) Open the inner bag and retrieve the mop immediately at the point of use; (8) Remove used packaging from the Grade A zone immediately. This is a general framework — each facility should validate and document its own transfer SOP based on its specific zone layout and airlock configuration.
Annex 1 does not explicitly mandate double-bagging as a prescriptive requirement. However, it requires that sterile items introduced into Grade A be transferred through a sterilized route or decontaminated pass-through, and that transfer procedures are validated and reproducible. Double-bagging is the industry-standard approach that demonstrably supports these requirements by enabling staged decontamination matching zone boundaries. A facility using single-bagging would need to provide a documented justification and risk assessment to demonstrate equivalent sterility assurance. The key principle is not the number of bags but the outcome: can the facility demonstrate that sterility is maintained through all transfer stages?
At receiving, perform visual inspection of all packaging seals (no gaps, tears, or incomplete seals), package surfaces (no punctures, abrasions, or compression damage), and internal environment (no visible moisture or condensation inside packaging). Cross-check the Certificate of Sterility batch number against the shipment batch/lot number. Verify the product is within its labeled sterility shelf life. Document all findings in incoming QA records. Any compromised packaging should trigger quarantine and documented disposition. For sterile products used in Grade A, a defined packaging integrity check procedure should be part of the material release SOP — not an informal step.
At minimum: (1) Certificate of Sterility with batch-specific traceability — links the specific shipment to a validated sterilization lot; (2) Certificate of Conformance confirming the product meets packaging and material specifications; (3) Batch/lot identification for internal traceability. Depending on facility requirements and cleanroom classification, additional documentation may include a Certificate of Analysis (COA), packaging integrity test data, material certification, and sterility assurance level documentation. Facilities should define their minimum documentation requirements during supplier qualification — not at the point of first shipment receipt. Documentation gaps identified at receiving are more difficult to resolve than those addressed during supplier evaluation.
The most frequent mistakes include: unwrapping all packaging layers outside the cleanroom (exposing the sterile mop to uncontrolled environments), skipping outer bag decontamination before airlock entry (introducing surface contaminants into the pass-through), treating all supplier packaging as equivalent without verifying packaging configuration during supplier qualification, not documenting packaging integrity checks at receiving (creating an audit documentation gap), assuming operator training is a one-time event (leading to procedural drift over time), and not requesting batch-level sterility documentation from the supplier (undermining batch release and audit defense). Each of these can be addressed through documented SOPs, training reinforcement, and periodic compliance review.
MIDPOSI provides sterile cleanroom mops in 40g, 55g, and 65g configurations — with packaging designed for staged aseptic transfer into Grade A/B zones. Batch-specific Certificate of Sterility and traceability documentation support your Annex 1 audit readiness. Contact us to discuss your sterile mop requirements, request documentation samples, or initiate a technical evaluation.
Sterile configurations across three weight classes for Grade A/B aseptic environments. Full batch-level traceability and sterility documentation provided as standard with every sterile shipment.
